AMBOSS
PrivateLast Round
Early Funding
Mar 25, 2025
Total Funding Raised
$304.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AMBOSS is a healthcare education company that provides a digital medical knowledge platform, exam preparation tools, and clinical decision support for medical students and healthcare professionals.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Vertical SaaS, Blockchain Infrastructure
Business Model
B2C
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMBOSS Comparables
Compare AMBOSS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NoveList | 78% | |
| Sanar | 78% | |
| Ascend Learning | 78% |
AMBOSS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 25, 2025 | ||||
| Series B | Sep 30, 2019 |
AMBOSS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Partech | Early Funding, Series B |
| Partech | Early Funding, Series B |
| LGT Private Banking | Early Funding |
| Target Global | Series B |
| M&G Investments | Early Funding |
| Partech Partners | Series B |
| Holtzbrinck Digital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Platform now used by over 1 million medical professionals globally.
- Apr 21, 2026
AI Mode offers structured, evidence-based explanations for medical questions.
AMBOSS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AMBOSS's valuation, stock price, and market status.
Is AMBOSS a public or private company?
AMBOSS is a private company.
What is the current stock price of AMBOSS?
AMBOSS is a private company with no public stock price. No recent secondary market data is available.
How much is AMBOSS worth (valuation)?
Valuation information for AMBOSS is not publicly available.
Can I buy AMBOSS stock?
AMBOSS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AMBOSS's last funding round?
AMBOSS's most recent funding round was Early Funding on March 25, 2025.
Who are the main investors in AMBOSS?
Key investors in AMBOSS include Partech, Partech, Target Global, Partech Partners, Lightrock.
Will AMBOSS IPO soon?
No public IPO plans have been announced for AMBOSS.
How can I track AMBOSS secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AMBOSS's secondary market activity and sign up for updates.